SCHEMBL6132076

SCHEMBL6132076

Nc1n[nH]c(-c2ccccc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.80
NPSR1 Q6W5P4 1/20 0.80
RPS6KA3 P51812 1/20 0.71
IKBKB O14920 1/20 0.58
MAP3K14 Q99558 1/20 0.58
AKT2 P31751 1/20 0.53
KMT2A Q03164 1/20 0.53
MAPK14 Q16539 1/20 0.53
CYP3A4 P08684 2/20 0.50
ILK Q13418 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
NR1H2 P55055 1/20 0.49
NR1H3 Q13133 1/20 0.49
ABL1 P00519 1/20 0.48
SRC P12931 1/20 0.48
GRM5 P41594 2/20 0.47
GAA P10253 2/20 0.46
CYP1A2 P05177 2/20 0.46
TP53 P04637 1/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5820038 0.89 MAPK1 (1.00) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132022 0.83 MAPK1 (0.80) MAPK1NPSR1RPS6KA3IKBKBMAP3K14
SCHEMBL6132067 0.83 MAPK1 (0.80) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132080 0.83 MAPK1 (0.80) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL5818294 0.83 MAPK1 (0.54) MAPK1NPSR1RPS6KA3IKBKBMAP3K14
SCHEMBL6132051 0.81 MAPK1 (0.83) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL8640607 0.80 MAPK1 (0.73) MAPK1NPSR1RPS6KA3AKT2KMT2A
SCHEMBL6132028 0.79 MAPK1 (0.67) MAPK1NPSR1RPS6KA3IKBKBMAP3K14
SCHEMBL8025184 0.77 ABL1 (0.54) MAPK1NPSR1RPS6KA3IKBKBMAP3K14
SCHEMBL13516075 0.77 IKBKB (0.68) MAPK1NPSR1RPS6KA3IKBKBMAP3K14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP disclosed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP disclosed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed